Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 726

1.

Role of the MEK inhibitor trametinib in the treatment of metastatic melanoma.

King JW, Nathan PD.

Future Oncol. 2014 Aug;10(9):1559-70. doi: 10.2217/fon.14.89.

PMID:
25145427
[PubMed - in process]
2.

A primary care audit of familial risk in patients with a personal history of breast cancer.

Nathan P, Ahluwalia A, Chorley W.

Fam Cancer. 2014 Aug 6. [Epub ahead of print]

PMID:
25096803
[PubMed - as supplied by publisher]
3.

NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus.

Chen JL, Dawoodji A, Tarlton A, Gnjatic S, Tajar A, Karydis I, Browning J, Pratap S, Verfaille C, Venhaus RR, Pan L, Altman DG, Cebon JS, Old LL, Nathan P, Ottensmeier C, Middleton M, Cerundolo V.

Int J Cancer. 2014 Aug 1. doi: 10.1002/ijc.29118. [Epub ahead of print]

PMID:
25081390
[PubMed - as supplied by publisher]
4.

Interpersonal problems across restrictive and binge-purge samples: Data from a community-based eating disorders clinic.

Raykos BC, McEvoy PM, Carter O, Fursland A, Nathan P.

Eat Behav. 2014 Aug;15(3):449-52. doi: 10.1016/j.eatbeh.2014.06.008. Epub 2014 Jun 21.

PMID:
25064298
[PubMed - in process]
5.

The development of scales to measure childhood cancer survivors' readiness for transition to long-term follow-up care as adults.

Klassen AF, Rosenberg-Yunger ZR, D'Agostino NM, Cano SJ, Barr R, Syed I, Granek L, Greenberg ML, Dix D, Nathan PC.

Health Expect. 2014 Jul 22. doi: 10.1111/hex.12241. [Epub ahead of print]

PMID:
25052198
[PubMed - as supplied by publisher]
6.

Impact of adverse events, treatment modifications, and dose intensity on survival among patients with advanced renal cell carcinoma treated with first-line sunitinib: a medical chart review across ten centers in five European countries.

Porta C, Levy A, Hawkins R, Castellano D, Bellmunt J, Nathan P, McDermott R, Wagstaff J, Donnellan P, McCaffrey J, Vekeman F, Neary MP, Diaz J, Mehmud F, Duh MS.

Cancer Med. 2014 Jul 18. doi: 10.1002/cam4.302. [Epub ahead of print]

PMID:
25045157
[PubMed - as supplied by publisher]
7.

Skeletal, neuromuscular and fitness impairments among children with newly diagnosed acute lymphoblastic leukemia.

Ness KK, Kaste SC, Zhu L, Pui CH, Jeha S, Nathan PC, Inaba H, Wasilewski-Masker K, Shah D, Wells RJ, Karlage RE, Robison LL, Cox CL.

Leuk Lymphoma. 2014 Aug 20:1-8. [Epub ahead of print]

PMID:
25030039
[PubMed - as supplied by publisher]
8.

Oxytocin Modulation of Amygdala Functional Connectivity to Fearful Faces in Generalized Social Anxiety Disorder.

Gorka SM, Fitzgerald DA, Labuschagne I, Hosanagar A, Wood AG, Nathan PJ, Phan KL.

Neuropsychopharmacology. 2014 Jul 7. doi: 10.1038/npp.2014.168. [Epub ahead of print]

PMID:
24998619
[PubMed - as supplied by publisher]
9.

Factors associated with recruiting adult survivors of childhood cancer into clinic-based research.

Mertens AC, Liu W, Ness KK, McDonald A, Hudson MM, Wasilewski-Masker K, Bhatia S, Nathan PC, Leonard M, Srivastava K, Robison LL, Green DM.

Pediatr Blood Cancer. 2014 Oct;61(10):1846-51. doi: 10.1002/pbc.25130. Epub 2014 Jun 29.

PMID:
24976622
[PubMed - in process]
10.

The opioid receptor pharmacology of GSK1521498 compared to other ligands with differential effects on compulsive reward-related behaviours.

Kelly E, Mundell SJ, Sava A, Roth AL, Felici A, Maltby K, Nathan PJ, Bullmore ET, Henderson G.

Psychopharmacology (Berl). 2014 Jun 29. [Epub ahead of print]

PMID:
24973897
[PubMed - as supplied by publisher]
11.

Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort.

Essig S, Li Q, Chen Y, Hitzler J, Leisenring W, Greenberg M, Sklar C, Hudson MM, Armstrong GT, Krull KR, Neglia JP, Oeffinger KC, Robison LL, Kuehni CE, Yasui Y, Nathan PC.

Lancet Oncol. 2014 Jul;15(8):841-51. doi: 10.1016/S1470-2045(14)70265-7. Epub 2014 Jun 19.

PMID:
24954778
[PubMed - in process]
12.

Effects of the KIBRA Single Nucleotide Polymorphism on Synaptic Plasticity and Memory: A Review of the Literature.

Schwab LC, Luo V, Clarke CL, Nathan PJ.

Curr Neuropharmacol. 2014 May;12(3):281-8. doi: 10.2174/1570159X11666140104001553.

PMID:
24851092
[PubMed]
13.

Decline in physical activity level in the childhood cancer survivor study cohort.

Wilson CL, Stratton K, Leisenring WL, Oeffinger KC, Nathan PC, Wasilewski-Masker K, Hudson MM, Castellino SM, Stovall M, Armstrong GT, Brinkman TM, Krull KR, Robison LL, Ness KK.

Cancer Epidemiol Biomarkers Prev. 2014 Aug;23(8):1619-27. doi: 10.1158/1055-9965.EPI-14-0213. Epub 2014 May 19.

PMID:
24842624
[PubMed - in process]
14.

Therapeutic alliance in Enhanced Cognitive Behavioural Therapy for bulimia nervosa: probably necessary but definitely insufficient.

Raykos BC, McEvoy PM, Erceg-Hurn D, Byrne SM, Fursland A, Nathan P.

Behav Res Ther. 2014 Jun;57:65-71. doi: 10.1016/j.brat.2014.04.004. Epub 2014 May 4.

PMID:
24841726
[PubMed - in process]
15.

The impact of 5-HTTLPR on acute serotonin transporter blockade by escitalopram on emotion processing: Preliminary findings from a randomised, crossover fMRI study.

Outhred T, Das P, Dobson-Stone C, Felmingham KL, Bryant RA, Nathan PJ, Malhi GS, Kemp AH.

Aust N Z J Psychiatry. 2014 May 8. [Epub ahead of print]

PMID:
24810870
[PubMed - as supplied by publisher]
16.

Neuroendocrine and sympathetic responses to an orexin receptor antagonist, SB-649868, and Alprazolam following insulin-induced hypoglycemia in humans.

Patel AX, Miller SR, Nathan PJ, Kanakaraj P, Napolitano A, Lawrence P, Koch A, Bullmore ET.

Psychopharmacology (Berl). 2014 Apr 26. [Epub ahead of print]

PMID:
24770625
[PubMed - as supplied by publisher]
17.

Identification of BDNF sensitive electrophysiological markers of synaptic activity and their structural correlates in healthy subjects using a genetic approach utilizing the functional BDNF Val66Met polymorphism.

Soltész F, Suckling J, Lawrence P, Tait R, Ooi C, Bentley G, Dodds CM, Miller SR, Wille DR, Byrne M, McHugh SM, Bellgrove MA, Croft RJ, Lu B, Bullmore ET, Nathan PJ.

PLoS One. 2014 Apr 23;9(4):e95558. doi: 10.1371/journal.pone.0095558. eCollection 2014.

PMID:
24760076
[PubMed - in process]
Free PMC Article
18.

Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study.

Corrie PG, Marshall A, Dunn JA, Middleton MR, Nathan PD, Gore M, Davidson N, Nicholson S, Kelly CG, Marples M, Danson SJ, Marshall E, Houston SJ, Board RE, Waterston AM, Nobes JP, Harries M, Kumar S, Young G, Lorigan P.

Lancet Oncol. 2014 May;15(6):620-30. doi: 10.1016/S1470-2045(14)70110-X. Epub 2014 Apr 15. Erratum in: Lancet Oncol. 2014 Jun;15(7):e253.

PMID:
24745696
[PubMed - indexed for MEDLINE]
Free Article
19.

Exercise intolerance and the impact of physical activity in children treated with hematopoietic stem cell transplantation.

West SL, Gassas A, Schechter T, Egeler RM, Nathan PC, Wells GD.

Pediatr Exerc Sci. 2014 Aug;26(3):358-64. doi: 10.1123/pes.2013-0156. Epub 2014 Apr 10.

PMID:
24721685
[PubMed - in process]
20.

Distribution of tract deficits in schizophrenia.

Ellison-Wright I, Nathan PJ, Bullmore ET, Zaman R, Dudas RB, Agius M, Fernandez-Egea E, Müller U, Dodds CM, Forde NJ, Scanlon C, Leemans A, McDonald C, Cannon DM.

BMC Psychiatry. 2014 Apr 2;14(1):99. [Epub ahead of print]

PMID:
24693962
[PubMed - as supplied by publisher]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk